406 related articles for article (PubMed ID: 15860672)
1. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha.
Nishio M; Endo T; Tsukada N; Ohata J; Kitada S; Reed JC; Zvaifler NJ; Kipps TJ
Blood; 2005 Aug; 106(3):1012-20. PubMed ID: 15860672
[TBL] [Abstract][Full Text] [Related]
2. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway.
Kern C; Cornuel JF; Billard C; Tang R; Rouillard D; Stenou V; Defrance T; Ajchenbaum-Cymbalista F; Simonin PY; Feldblum S; Kolb JP
Blood; 2004 Jan; 103(2):679-88. PubMed ID: 14504101
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.
He B; Chadburn A; Jou E; Schattner EJ; Knowles DM; Cerutti A
J Immunol; 2004 Mar; 172(5):3268-79. PubMed ID: 14978135
[TBL] [Abstract][Full Text] [Related]
4. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.
Endo T; Nishio M; Enzler T; Cottam HB; Fukuda T; James DF; Karin M; Kipps TJ
Blood; 2007 Jan; 109(2):703-10. PubMed ID: 16973958
[TBL] [Abstract][Full Text] [Related]
5. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
[TBL] [Abstract][Full Text] [Related]
6. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.
Moreaux J; Legouffe E; Jourdan E; Quittet P; Rème T; Lugagne C; Moine P; Rossi JF; Klein B; Tarte K
Blood; 2004 Apr; 103(8):3148-57. PubMed ID: 15070697
[TBL] [Abstract][Full Text] [Related]
7. Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia.
Tsukada N; Burger JA; Zvaifler NJ; Kipps TJ
Blood; 2002 Feb; 99(3):1030-7. PubMed ID: 11807009
[TBL] [Abstract][Full Text] [Related]
8. Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.
Cols M; Barra CM; He B; Puga I; Xu W; Chiu A; Tam W; Knowles DM; Dillon SR; Leonard JP; Furman RR; Chen K; Cerutti A
J Immunol; 2012 Jun; 188(12):6071-83. PubMed ID: 22593611
[TBL] [Abstract][Full Text] [Related]
9. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.
Burger JA; Tsukada N; Burger M; Zvaifler NJ; Dell'Aquila M; Kipps TJ
Blood; 2000 Oct; 96(8):2655-63. PubMed ID: 11023495
[TBL] [Abstract][Full Text] [Related]
10. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.
Haiat S; Billard C; Quiney C; Ajchenbaum-Cymbalista F; Kolb JP
Immunology; 2006 Jul; 118(3):281-92. PubMed ID: 16827889
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survival.
Maia S; Pelletier M; Ding J; Hsu YM; Sallan SE; Rao SP; Nadler LM; Cardoso AA
PLoS One; 2011; 6(6):e20787. PubMed ID: 21687682
[TBL] [Abstract][Full Text] [Related]
12. BAFF and the regulation of B cell survival.
Schneider P; Tschopp J
Immunol Lett; 2003 Jul; 88(1):57-62. PubMed ID: 12853163
[TBL] [Abstract][Full Text] [Related]
13. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells.
Yang M; Hase H; Legarda-Addison D; Varughese L; Seed B; Ting AT
J Immunol; 2005 Sep; 175(5):2814-24. PubMed ID: 16116167
[TBL] [Abstract][Full Text] [Related]
14. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.
Kayagaki N; Yan M; Seshasayee D; Wang H; Lee W; French DM; Grewal IS; Cochran AG; Gordon NC; Yin J; Starovasnik MA; Dixit VM
Immunity; 2002 Oct; 17(4):515-24. PubMed ID: 12387744
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.
Jasek M; Wagner M; Sobczynski M; Wolowiec D; Kuliczkowski K; Woszczyk D; Kielbinski M; Kusnierczyk P; Frydecka I; Karabon L
Tissue Antigens; 2015 Oct; 86(4):279-84. PubMed ID: 26268376
[TBL] [Abstract][Full Text] [Related]
16. The TNF family members BAFF and APRIL: the growing complexity.
Mackay F; Ambrose C
Cytokine Growth Factor Rev; 2003; 14(3-4):311-24. PubMed ID: 12787568
[TBL] [Abstract][Full Text] [Related]
17. APRIL and BAFF promote increased viability of replicating human B2 cells via mechanism involving cyclooxygenase 2.
Mongini PK; Inman JK; Han H; Fattah RJ; Abramson SB; Attur M
J Immunol; 2006 Jun; 176(11):6736-51. PubMed ID: 16709833
[TBL] [Abstract][Full Text] [Related]
18. TNF-alpha mediates SDF-1 alpha-induced NF-kappa B activation and cytotoxic effects in primary astrocytes.
Han Y; He T; Huang DR; Pardo CA; Ransohoff RM
J Clin Invest; 2001 Aug; 108(3):425-35. PubMed ID: 11489936
[TBL] [Abstract][Full Text] [Related]
19. A role of both NF-κB pathways in expression and transcription regulation of BAFF-R gene in multiple myeloma cells.
Shen X; Zhu W; Zhang X; Xu G; Ju S
Mol Cell Biochem; 2011 Nov; 357(1-2):21-30. PubMed ID: 21607696
[TBL] [Abstract][Full Text] [Related]
20. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
